SEC Tracker
Get the app

ABVC BioPharma ABVC

ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results

Form
8-K/A
Filed
Importance
Routine
  • Reports quarterly results (2.02)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when ABVC BioPharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Karyopharm Therapeutics KPTI public float $37M, Jun 30, 2025
  2. BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
  3. Annovis Bio ANVS public float $36M, Jun 30, 2025
  4. Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025
  5. Grace Therapeutics GRCE public float $35M, Sep 30, 2025